Renal Insufficiency  >>  AZD1656  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AZD1656 / Conduit Pharmaceuticals
NCT01069926: To Assess the Pharmacokinetics of AZD1656 and Its Metabolite in Type 2 Diabetes Mellitus Patients

Completed
1
21
US
AZD1656
AstraZeneca
Glucose Lowering
10/10
10/10

Download Options